Literature DB >> 7892190

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

P Eriksson1, B Kallin, F M van 't Hooft, P Båvenholm, A Hamsten.   

Abstract

Increased plasminogen-activator inhibitor 1 (PAI-1) activity is a common finding in patients with coronary heart disease. Here we provide evidence for an independent, etiological role of PAI-1 in myocardial infarction. The 4G allele of a recently described common 4/5-guanine-tract (4G/5G) polymorphism in the PAI-1 promoter is associated with higher plasma PAI-1 activity. The prevalence of the 4G allele is significantly higher in patients with myocardial infarction before the age of 45 than in population-based controls (allele frequencies of 0.63 vs. 0.53). Both alleles bind a transcriptional activator, whereas the 5G allele also binds a repressor protein to an overlapping binding site. In the absence of bound repressor, the basal level of PAI-1 transcription is increased.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7892190      PMCID: PMC42380          DOI: 10.1073/pnas.92.6.1851

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Protein-protein contacts in the glucocorticoid receptor homodimer influence its DNA binding properties.

Authors:  P Eriksson; O Wrange
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

2.  A new spectrophotometric assay for protein in cell extracts.

Authors:  V F Kalb; R W Bernlohr
Journal:  Anal Biochem       Date:  1977-10       Impact factor: 3.365

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Stoichiometric analysis of the specific interaction of the glucocorticoid receptor with DNA.

Authors:  O Wrange; J Carlstedt-Duke; J A Gustafsson
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

5.  Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor.

Authors:  C L Lucore; S Fujii; T C Wun; B E Sobel; J J Billadello
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

6.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

7.  Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.

Authors:  E K Kruithof; C Tran-Thang; A Ransijn; F Bachmann
Journal:  Blood       Date:  1984-10       Impact factor: 22.113

8.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

9.  Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene.

Authors:  L A Erickson; G J Fici; J E Lund; T P Boyle; H G Polites; K R Marotti
Journal:  Nature       Date:  1990-07-05       Impact factor: 49.962

10.  Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age.

Authors:  K Malmberg; P Båvenholm; A Hamsten
Journal:  J Am Coll Cardiol       Date:  1994-09       Impact factor: 24.094

View more
  116 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

Review 2.  The impact of molecular medicine upon early cardiovascular drug development.

Authors:  M W Lunnon; M Braddock
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

3.  4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.

Authors:  Francesco Burzotta; Licia Iacoviello; Augusto Di Castelnuovo; Roberto Zamparelli; Andria D'Orazio; Concetta Amore; Rocco Schiavello; Maria Benedetta Donati; Attilio Maseri; GianFederico Possati; Felicita Andreotti
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

4.  A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey.

Authors:  Serif Yilmaz; Kadim Bayan; Yekta Tüzün; Sabri Batun; Abdullah Altintaş
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

5.  Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression.

Authors:  Mark D Sternlicht; Alison M Dunning; Dan H Moore; Paul D P Pharoah; David G Ginzinger; Koei Chin; Joe W Gray; Frederic M Waldman; Bruce A J Ponder; Zena Werb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

6.  4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.

Authors:  Sachin Yende; Derek C Angus; Jingzhong Ding; Anne B Newman; John A Kellum; Rongling Li; Robert E Ferrell; Joseph Zmuda; Stephen B Kritchevsky; Tamara B Harris; Melissa Garcia; Kristine Yaffe; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

7.  Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G/5G alleles frequency distribution in the Lebanese population.

Authors:  Dina M R Shammaa; Amira S Sabbagh; Ali T Taher; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2007-06-20       Impact factor: 2.316

8.  Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk.

Authors:  Luqian Zhao; Ping Huang
Journal:  Int J Clin Exp Med       Date:  2013-09-01

9.  Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population.

Authors:  J A Schoenhard; F W Asselbergs; K A Poku; S A Stocki; S Gordon; D E Vaughan; N J Brown; J H Moore; Scott M Williams
Journal:  Hum Genet       Date:  2008-10-25       Impact factor: 4.132

10.  Association between the rs6950982 polymorphism near the SERPINE1 gene and blood pressure and lipid parameters in a high-cardiovascular-risk population: interaction with Mediterranean diet.

Authors:  Mercedes Sotos-Prieto; Marisa Guillén; Olga Portolés; José V Sorlí; José I González; Eva M Asensio; Dolores Corella
Journal:  Genes Nutr       Date:  2012-12-09       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.